Free Trial

MarketBeat Instant News Alerts

J. M. Smucker logo with Consumer Staples background

J. M. Smucker (NYSE:SJM) Price Target Raised to $118.00

Morgan Stanley increased their price objective on shares of J. M. Smucker from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Monday.

NYSE:SJM
Read J. M. Smucker (NYSE:SJM) Price Target Raised to $118.00
Primerica logo with Finance background

Primerica (NYSE:PRI) Price Target Raised to $308.00 at Morgan Stanley

Morgan Stanley raised their price target on Primerica from $292.00 to $308.00 and gave the stock an "equal weight" rating in a research report on Monday.

NYSE:PRI
Read Primerica (NYSE:PRI) Price Target Raised to $308.00 at Morgan Stanley
Principal Financial Group logo with Finance background

Morgan Stanley Forecasts Strong Price Appreciation for Principal Financial Group (NYSE:PFG) Stock

Morgan Stanley boosted their target price on shares of Principal Financial Group from $75.00 to $77.00 and gave the stock an "underweight" rating in a research report on Monday.

NYSE:PFG
Read Morgan Stanley Forecasts Strong Price Appreciation for Principal Financial Group (NYSE:PFG) Stock
Matador Resources logo with Energy background

Morgan Stanley Increases Matador Resources (NYSE:MTDR) Price Target to $62.00

Morgan Stanley upped their target price on shares of Matador Resources from $60.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday.

NYSE:MTDR
Read Morgan Stanley Increases Matador Resources (NYSE:MTDR) Price Target to $62.00
Marsh & McLennan Companies logo with Finance background

Morgan Stanley Lowers Marsh & McLennan Companies (NYSE:MMC) Price Target to $220.00

Morgan Stanley dropped their price target on Marsh & McLennan Companies from $225.00 to $220.00 and set an "equal weight" rating for the company in a report on Monday.

NYSE:MMC
Read Morgan Stanley Lowers Marsh & McLennan Companies (NYSE:MMC) Price Target to $220.00
MetLife logo with Finance background

MetLife (NYSE:MET) Given New $94.00 Price Target at Morgan Stanley

Morgan Stanley reduced their price target on shares of MetLife from $98.00 to $94.00 and set an "overweight" rating for the company in a report on Monday.

NYSE:MET
Read MetLife (NYSE:MET) Given New $94.00 Price Target at Morgan Stanley

Trending News

All MarketBeat Instant News Alerts

Lincoln National logo with Finance background

Lincoln National (NYSE:LNC) Stock Price Expected to Rise, Morgan Stanley Analyst Says

NYSE:LNC
Read Lincoln National (NYSE:LNC) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Jackson Financial logo with Finance background

Jackson Financial (NYSE:JXN) Stock Price Expected to Rise, Morgan Stanley Analyst Says

NYSE:JXN
Read Jackson Financial (NYSE:JXN) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Hamilton Insurance Group logo with Finance background

Morgan Stanley Issues Positive Forecast for Hamilton Insurance Group (NYSE:HG) Stock Price

NYSE:HG
Read Morgan Stanley Issues Positive Forecast for Hamilton Insurance Group (NYSE:HG) Stock Price
Globe Life logo with Finance background

Morgan Stanley Raises Globe Life (NYSE:GL) Price Target to $171.00

NYSE:GL
Read Morgan Stanley Raises Globe Life (NYSE:GL) Price Target to $171.00
Equitable logo with Finance background

Morgan Stanley Lowers Equitable (NYSE:EQH) Price Target to $67.00

NYSE:EQH
Read Morgan Stanley Lowers Equitable (NYSE:EQH) Price Target to $67.00
Crown Castle logo with Finance background

Crown Castle (NYSE:CCI) Price Target Cut to $119.00 by Analysts at Barclays

NYSE:CCI
Read Crown Castle (NYSE:CCI) Price Target Cut to $119.00 by Analysts at Barclays
Okta logo with Computer and Technology background

Okta (NASDAQ:OKTA) Given Buy Rating at Guggenheim

NASDAQ:OKTA
Read Okta (NASDAQ:OKTA) Given Buy Rating at Guggenheim
Disc Medicine logo with Medical background

Morgan Stanley Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock

NASDAQ:IRON
Read Morgan Stanley Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock
Denali Therapeutics logo with Medical background

Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $30.00 at Morgan Stanley

NASDAQ:DNLI
Read Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $30.00 at Morgan Stanley
Cullinan Therapeutics logo with Medical background

Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price

NASDAQ:CGEM
Read Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price
Braze logo with Computer and Technology background

Braze (NASDAQ:BRZE) Price Target Cut to $35.00 by Analysts at Barclays

NASDAQ:BRZE
Read Braze (NASDAQ:BRZE) Price Target Cut to $35.00 by Analysts at Barclays
Imaflex logo with Consumer Cyclical background

Imaflex (CVE:IFX) Trading Down 6.3% - What's Next?

CVE:IFX
Read Imaflex (CVE:IFX) Trading Down 6.3% - What's Next?
Banyan Gold logo with Basic Materials background

Banyan Gold (CVE:BYN) Trading Up 5% - Here's Why

CVE:BYN
Read Banyan Gold (CVE:BYN) Trading Up 5% - Here's Why
Petra Diamonds logo with Basic Materials background

Petra Diamonds (LON:PDL) Trading 8.4% Higher - Here's What Happened

LON:PDL
Read Petra Diamonds (LON:PDL) Trading 8.4% Higher - Here's What Happened
MAST Energy Developments logo with Utilities background

MAST Energy Developments (LON:MAST) Shares Up 8.8% - Should You Buy?

LON:MAST
Read MAST Energy Developments (LON:MAST) Shares Up 8.8% - Should You Buy?
Sompo logo with Finance background

Short Interest in Sompo Holdings, Inc. Unsponsored ADR (OTCMKTS:SMPNY) Drops By 48.9%

OTCMKTS:SMPNY
Read Short Interest in Sompo Holdings, Inc. Unsponsored ADR (OTCMKTS:SMPNY) Drops By 48.9%
Sumitomo logo with Multi-Sector Conglomerates background

Short Interest in Sumitomo Corp. (OTCMKTS:SSUMY) Declines By 44.4%

OTCMKTS:SSUMY
Read Short Interest in Sumitomo Corp. (OTCMKTS:SSUMY) Declines By 44.4%
McGraw Hill logo with Manufacturing background

McGraw Hill, Inc. (NYSE:MH) Given Average Recommendation of "Moderate Buy" by Brokerages

NYSE:MH
Read McGraw Hill, Inc. (NYSE:MH) Given Average Recommendation of "Moderate Buy" by Brokerages
Smith & Nephew SNATS logo with Medical background

Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Average Rating of "Hold" from Analysts

NYSE:SNN
Read Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Average Rating of "Hold" from Analysts
Palo Alto Networks logo with Computer and Technology background

Palo Alto Networks (NASDAQ:PANW) Given Buy Rating at DA Davidson

NASDAQ:PANW
Read Palo Alto Networks (NASDAQ:PANW) Given Buy Rating at DA Davidson
Palo Alto Networks logo with Computer and Technology background

Palo Alto Networks' (PANW) "Outperform" Rating Reaffirmed at Wedbush

NASDAQ:PANW
Read Palo Alto Networks' (PANW) "Outperform" Rating Reaffirmed at Wedbush
Palo Alto Networks logo with Computer and Technology background

Palo Alto Networks' (PANW) "Equal Weight" Rating Reiterated at Stephens

NASDAQ:PANW
Read Palo Alto Networks' (PANW) "Equal Weight" Rating Reiterated at Stephens
Riskified logo with Computer and Technology background

Riskified (NYSE:RSKD) Posts Earnings Results, Misses Expectations By $0.09 EPS

NYSE:RSKD
Read Riskified (NYSE:RSKD) Posts Earnings Results, Misses Expectations By $0.09 EPS
Pharvaris logo with Medical background

Pharvaris N.V. (NASDAQ:PHVS) Short Interest Update

NASDAQ:PHVS
Read Pharvaris N.V. (NASDAQ:PHVS) Short Interest Update

Featured Articles and Offers

Sector News